GSTM1 and neoplasm: Total body radioactivity (Figure 3C) was observed to decrease with increasing dose of RRx-001 (p < 0.05 at 10 mg/kg compared to vehicle) likely as we are underestimating the volume of treated RBCs in the tumor due to competition between 99mTc and RRx-001 Hb binding.